Biological rationale for regular physical exercise as an effective intervention for the prevention and treatment of depressive disorders

Current Pharmaceutical Design

Volumn 22, Issue 24, 2016, Pages 3764-3775

  Pareja Galeano, Helios ^a,b   Mayero, Sara ^c   Perales, María ^b,d   Garatachea, Nuria ^b,e   Santos Lozano, Alejandro ^b,f   Fiuza Luces, Carmen ^b   Emanuele, Enzo ^g   Gálvez, Beatriz G ^a,h   Sanchis Gomar, Fabian ^b   Lucia, Alejandro ^a,b  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Hospital Moncloa   (Spain)

^d CAMILO JOSÉ CELA UNIVERSITY   (Spain)

^e UNIVERSITY OF ZARAGOZA   (Spain)

^f EUROPEAN UNIVERSITY MIGUEL DE CERVANTES   (Spain)

^g 2E Science ^*  (Italy)

^h CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Antidepressant; Brain derived neurotrophic factor; Major depression; Neurogenesis; Physical activity; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; HORMONE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN;

AEROBIC EXERCISE; ANTIDEPRESSANT ACTIVITY; BRAIN REGION; BRAIN SIZE; CARDIORESPIRATORY FITNESS; CELL AGING; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DSM-5; EXERCISE; HUMAN; IMMUNOMODULATION; INFLAMMATION; META ANALYSIS (TOPIC); MUSCLE TRAINING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; RESISTANCE TRAINING; REVIEW; SYSTEMATIC REVIEW (TOPIC); TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; THERAPY EFFECT; METABOLISM; PATHOPHYSIOLOGY;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; EXERCISE; HUMANS; SEROTONIN;

EID: 84978194750     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666160322144537     Document Type: Review

References (208)

1. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressivedisorders by country, sex, age, and year: findings from the globalburden of disease study 2010. PLoS Med 2013; 10: e1001547.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology ofmajor depressive disorder: results from the National ComorbiditySurvey Replication (NCS-R). JAMA 2003; 289: 3095-105.
3. Maes M, Yirmyia R, Noraberg J, et al. The inflammatory and neurodegenerative(IandND) hypothesis of depression: leads for futureresearch and new drug developments in depression. Metab BrainDis 2009; 24: 27-53.
4. Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J. A systematicreview and meta-analysis of dietary patterns and depressionin community-dwelling adults. Am J Clin Nutr 2014; 99: 181-97.
5. Cooney GM, Dwan K, Greig CA, et al. Exercise for depression.Cochrane Database Syst Rev 2013; 9: CD004366.
6. Silveira H, Moraes H, Oliveira N, Coutinho ES, Laks J, Deslandes A. Physical exercise and clinically depressed patients: a systematicreview and meta-analysis. Neuropsychobiology 2013; 67: 61-8.
7. Josefsson T, Lindwall M, Archer T. Physical exercise interventionin depressive disorders: meta-analysis and systematic review. Scand J Med Sci Sports 2014; 24: 259-72.
8. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a majorcause of chronic diseases. Compr Physiol 2012; 2: 1143-211.
9. Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribingexercise as therapy in 26 different chronic diseases. ScandJ Med Sci Sports 2015; 25 Suppl 3: 1-72.
10. Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is thereal polypill. Physiology (Bethesda) 2013; 28: 330-58.
11. Pareja-Galeano H, Garatachea N, Lucia A. Exercise as a Polypillfor Chronic Diseases. Prog Mol Biol Transl Sci 2015; 135: 497-526.
12. Thirlaway K, Benton D. Participation in physical activity and cardiovascularfitness have different effects on mental health andmood. J Psychosom Res 1992; 36: 657-65.
13. Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB. Inverseassociation between physical inactivity and mental health inmen and women. Med Sci Sports Exerc 2006; 38: 173-8.
14. Tolmunen T, Laukkanen JA, Hintikka J, et al. Low maximal oxygenuptake is associated with elevated depressive symptoms inmiddle-aged men. Eur J Epidemiol 2006; 21: 701-6.
15. Paffenbarger RS, Jr., Lee IM, Leung R. Physical activity and personalcharacteristics associated with depression and suicide inAmerican college men. Acta Psychiatr Scand Suppl 1994; 377: 16-22.
16. Sui X, Laditka JN, Church TS, et al. Prospective study of cardiorespiratoryfitness and depressive symptoms in women and men. JPsychiatr Res 2009; 43: 546-52.
17. Phillips C, Baktir MA, Srivatsan M, Salehi A. Neuroprotectiveeffects of physical activity on the brain: a closer look at trophic factorsignaling. Front Cell Neurosci 2014; 8: 170.
18. Cooney G, Dwan K, Mead G. Exercise for Depression. JAMA2014; 311: 2432-2433.
19. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev 2009: CD004366.
20. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology ofmajor depressive disorder: results from the National EpidemiologicSurvey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097-106.
21. Mathers CD, Loncar D. Projections of global mortality and burdenof disease from 2002 to 2030. PLoS Med 2006; 3: e442.
22. Kessler RC, Bromet EJ. The epidemiology of depression acrosscultures. Annu Rev Public Health 2013; 34: 119-38.
23. Patton GC, Coffey C, Romaniuk H, et al. The prognosis of commonmental disorders in adolescents: a 14-year prospective cohortstudy. Lancet 2014; 383(9928): 1548.
24. American Psychiatric Association. Diagnostic and Statistical Manualof Mental Disorders. 5th ed. Washington, DC 2013.
25. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902.
26. Berton O, Nestler EJ. New approaches to antidepressant drug discovery:beyond monoamines. Nat Rev Neurosci 2006; 7: 137-51.
27. Ruhe HG, Mason NS, Schene AH. Mood is indirectly related toserotonin, norepinephrine and dopamine levels in humans: a metaanalysisof monoamine depletion studies. Mol Psychiatry 2007; 12:331-59.
28. Kerman IA. New insights into BDNF signaling: relevance to majordepression and antidepressant action. Am J Psychiatry 2012; 169:1137-40.
29. Koch JM, Hinze-Selch D, Stingele K, et al. Changes in CREBphosphorylation and BDNF plasma levels during psychotherapy ofdepression. Psychother Psychosom 2009; 78: 187-92.
30. Monteggia LM, Luikart B, Barrot M, et al. Brain-derived neurotrophicfactor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007; 61: 187-97.
31. Monteggia LM, Barrot M, Powell CM, et al. Essential role ofbrain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004; 101: 10827-32.
32. Schildkraut JJ. The catecholamine hypothesis of affective disorders:a review of supporting evidence. Am J Psychiatry 1965; 122:509-22.
33. Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, Silva CT, Fleck MP. Neurobiological effects of exercise on major depressivedisorder: A systematic review. Neurosci Biobehav Rev 2016; 61: 1-11.
34. Song C, Wang H. Cytokines mediated inflammation and decreasedneurogenesis in animal models of depression. Prog NeuropsychopharmacolBiol Psychiatry 2011; 35: 760-8.
35. Brunoni AR, Lopes M, Fregni F. A systematic review and metaanalysisof clinical studies on major depression and BDNF levels:implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169-80.
36. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis ofcytokines in major depression. Biol Psychiatry 2010; 67: 446-57.
37. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: asystematic review and meta-analysis of longitudinal studies. J AffectDisord 2013; 150: 736-44.
38. Lopresti AL, Maker GL, Hood SD, Drummond PD. A review ofperipheral biomarkers in major depression: the potential of inflammatoryand oxidative stress biomarkers. Prog NeuropsychopharmacolBiol Psychiatry 2014; 48: 102-11.
39. Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF, Gotlib IH. Functional neuroimaging of major depressive disorder: a metaanalysisand new integration of base line activation and neural responsedata. Am J Psychiatry 2012; 169: 693-703.
40. Soares JC, Mann JJ. The anatomy of mood disorders--review ofstructural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
41. Steffens DC, Krishnan KR. Structural neuroimaging and mooddisorders: recent findings, implications for classification, and futuredirections. Biol Psychiatry 1998; 43: 705-12.
42. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomeswith citalopram for depression using measurement-basedcare in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40.
43. Driessen E, Hollon SD. Cognitive behavioral therapy for mooddisorders: efficacy, moderators and mediators. Psychiatr Clin NorthAm 2010; 33: 537-55.
44. Cuijpers P. Combined pharmacotherapy and psychotherapy in thetreatment of mild to moderate major depression? JAMA Psychiatry 2014; 71: 747-8.
45. Bridle C, Spanjers K, Patel S, Atherton NM, Lamb SE. Effect ofexercise on depression severity in older people: systematic reviewand meta-analysis of randomised controlled trials. Br J Psychiatry 2012; 201: 180-5.
46. Krogh J, Nordentoft M, Sterne JA, Lawlor DA. The effect of exercisein clinically depressed adults: systematic review and metaanalysisof randomized controlled trials. J Clin Psychiatry 2011;72: 529-38.
47. Physical Activity Guidelines Advisory Committee. Physical ActivityGuidelines Advisory Committee Report. Available at: http://wwwhealthgov/paguidelines/Report/pdf/CommitteeReportpdf, 2008.
48. Mammen G, Faulkner G. Physical activity and the prevention ofdepression: a systematic review of prospective studies. Am J PrevMed 2013; 45: 649-57.
49. Sarris J, O'Neil A, Coulson CE, Schweitzer I, Berk M. Lifestylemedicine for depression. BMC Psychiatry 2014; 14: 107.
50. Dishman RK, Sui X, Church TS, Hand GA, Trivedi MH, Blair SN. Decline in cardiorespiratory fitness and odds of incident depression.Am J Prev Med 2012; 43: 361-8.
51. Rebar AL, Stanton R, Geard D, Short C, Duncan MJ, Vandelanotte C. A meta-meta-analysis of the effect of physical activity on depressionand anxiety in non-clinical adult populations. Health PsycholRev 2015: 1-13.
52. Silveira H, Deslandes AC, de Moraes H, et al. Effects of exerciseon electroencephalographic mean frequency in depressed elderlysubjects. Neuropsychobiology 2010; 61: 141-7.
53. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO.Exercise treatment for depression: efficacy and dose response. AmJ Prev Med 2005; 28: 1-8.
54. Colcombe SJ, Erickson KI, Scalf PE, et al. Aerobic exercise trainingincreases brain volume in aging humans. J Gerontol A Biol SciMed Sci 2006; 61: 1166-70.
55. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis inthe adult human hippocampus. Nat Med 1998; 4: 1313-7.
56. Radak Z, Ihasz F, Koltai E, Goto S, Taylor AW, Boldogh I. Theredox-associated adaptive response of brain to physical exercise. Free Radic Res 2014; 48: 84-92.
57. Moylan S, Maes M, Wray NR, Berk M. The neuroprogressivenature of major depressive disorder: pathways to disease evolutionand resistance, and therapeutic implications. Mol Psychiatry 2013;18: 595-606.
58. Vivar C, Potter MC, van Praag H. All about running: synapticplasticity, growth factors and adult hippocampal neurogenesis. CurrTop Behav Neurosci 2013; 15: 189-220.
59. van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhancesneurogenesis, learning, and long-term potentiation in mice.Proc Natl Acad Sci USA 1999; 96: 13427-31.
60. Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT.Learning causes synaptogenesis, whereas motor activity causes angiogenesis,in cerebellar cortex of adult rats. Proc Natl Acad SciUSA 1990; 87: 5568-72.
61. Rhyu IJ, Bytheway JA, Kohler SJ, et al. Effects of aerobic exercisetraining on cognitive function and cortical vascularity in monkeys.Neuroscience 2010; 167: 1239-48.
62. Cotman CW, Berchtold NC. Exercise: a behavioral intervention toenhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301.
63. Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J. Neurobiology of depression: an integrated view of key findings. IntJ Clin Pract 2007; 61: 2030-40.
64. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlledtrial of problem solving treatment, antidepressant medication,and combined treatment for major depression in primary care.BMJ 2000; 320: 26-30.
65. Dishman RK, Berthoud HR, Booth FW, et al. Neurobiology ofexercise. Obesity (Silver Spring) 2006; 14: 345-56.
66. Bailey SP, Davis JM, Ahlborn EN. Neuroendocrine and substrateresponses to altered brain 5-HT activity during prolonged exerciseto fatigue. J Appl Physiol (1985) 1993; 74: 3006-12.
67. Chaouloff F, Elghozi JL, Guezennec Y, Laude D. Effects of conditionedrunning on plasma, liver and brain tryptophan and on brain5-hydroxytryptamine metabolism of the rat. Br J Pharmacol 1985;86: 33-41.
68. Greenwood BN, Fleshner M. Exercise, stress resistance, and centralserotonergic systems. Exerc Sport Sci Rev 2011; 39: 140-9.
69. Melancon MO, Lorrain D, Dionne IJ. Exercise increases tryptophanavailability to the brain in older men age 57-70 years. MedSci Sports Exerc 2012; 44: 881-7.
70. Valim V, Natour J, Xiao Y, et al. Effects of physical exercise onserum levels of serotonin and its metabolite in fibromyalgia: a randomizedpilot study. Rev Bras Reumatol 2013; 53: 538-41.
71. Weicker H, Struder HK. Influence of exercise on serotonergicneuromodulation in the brain. Amino Acids 2001; 20: 35-47.
72. Greenwood BN, Strong PV, Brooks L, Fleshner M. Anxiety-likebehaviors produced by acute fluoxetine administration in maleFischer 344 rats are prevented by prior exercise. Psychopharmacology(Berl) 2008; 199: 209-22.
73. Lopresti AL, Hood SD, Drummond PD. A review of lifestyle factorsthat contribute to important pathways associated with majordepression: diet, sleep and exercise. J Affect Disord 2013; 148: 12-27.
74. Meeusen R, De Meirleir K. Exercise and brain neurotransmission.Sports Med 1995; 20: 160-88.
75. Giannaki CD, Sakkas GK, Karatzaferi C, et al. Effect of exercisetraining and dopamine agonists in patients with uremic restless legssyndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol 2013; 14: 194.
76. Pariante CM, Lightman SL. The HPA axis in major depression:classical theories and new developments. Trends Neurosci 2008;31: 464-8.
77. aan het Rot M, Collins KA, Fitterling HL. Physical exercise anddepression. Mt Sinai J Med 2009; 76: 204-14.
78. Sutton JR, Young JD, Lazarus L, Hickie JB, Maksvytis J. Thehormonal response to physical exercise. Aust Ann Med 1969; 18:84-90.
79. Luger A, Deuster PA, Kyle SB, et al. Acute hypothalamicpituitary-adrenal responses to the stress of treadmill exercise.Physiologic adaptations to physical training. N Engl J Med 1987;316: 1309-15.
80. Stranahan AM, Lee K, Mattson MP. Central mechanisms of HPAaxis regulation by voluntary exercise. Neuromol Med 2008; 10:118-27.
81. Dunn AL, Dishman RK. Exercise and the neurobiology of depression.Exerc Sport Sci Rev 1991; 19: 41-98.
82. Morgan WP. Affective beneficence of vigorous physical activity.Med Sci Sports Exerc 1985; 17: 94-100.
83. Carr DB, Bullen BA, Skrinar GS, et al. Physical conditioning facilitatesthe exercise-induced secretion of beta-endorphin and betalipotropinin women. N Engl J Med 1981; 305: 560-3.
84. Gambert SR, Garthwaite TL, Pontzer CH, et al. Running elevatesplasma beta-endorphin immunoreactivity and ACTH in untrainedhuman subjects. Proc Soc Exp Biol Med 1981; 168: 1-4.
85. Farrell PA, Gates WK, Maksud MG, Morgan WP. Increases inplasma beta-endorphin/beta-lipotropin immunoreactivity aftertreadmill running in humans. J Appl Physiol Respir Environ ExercPhysiol 1982; 52: 1245-9.
86. Wildmann J, Kruger A, Schmole M, Niemann J, Matthaei H. Increaseof circulating beta-endorphin-like immunoreactivity correlateswith the change in feeling of pleasantness after running. LifeSci 1986; 38: 997-1003.
87. Boecker H, Sprenger T, Spilker ME, et al. The runner's high:opioidergic mechanisms in the human brain. Cereb Cortex 2008;18: 2523-31.
88. Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br JSports Med 2004; 38: 536-41.
89. Fuss J, Gass P. Endocannabinoids and voluntary activity in mice:runner's high and long-term consequences in emotional behaviors.Exp Neurol 2010; 224: 103-5.
90. Fuss J, Steinle J, Bindila L, et al. A runner's high depends on cannabinoidreceptors in mice. Proc Natl Acad Sci USA 2015; 112:13105-8.
91. Antkiewicz-Michaluk L, Rokosz-Pelc A, Vetulani J. Effect ofelectroconvulsive treatment on cerebral opioid receptors in the rat:changes in delta but not mu receptors. Naunyn SchmiedebergsArch Pharmacol 1984; 328: 87-9.
92. Stengaard-Pedersen K, Schou M. Opioid receptors in the brain ofthe rat following chronic treatment with desipramine and electroconvulsiveshock. Neuropharmacology 1986; 25: 1365-71.
93. Gross-Isseroff R, Dillon KA, Israeli M, Biegon A. Regionallyselective increases in mu opioid receptor density in the brains ofsuicide victims. Brain Res 1990; 530: 312-6.
94. Gabilondo AM, Meana JJ, Garcia-Sevilla JA. Increased density ofmu-opioid receptors in the postmortem brain of suicide victims.Brain Res 1995; 682: 245-50.
95. Kennedy SE, Koeppe RA, Young EA, Zubieta JK. Dysregulationof endogenous opioid emotion regulation circuitry in major depressionin women. Arch Gen Psychiatry 2006; 63: 1199-208.
96. Hill MN, Carrier EJ, McLaughlin RJ, et al. Regional alterations inthe endocannabinoid system in an animal model of depression: effectsof concurrent antidepressant treatment. J Neurochem 2008;106: 2322-36.
97. Anisman H, Hayley S. Inflammatory factors contribute to depressionand its comorbid conditions. Sci Signal 2012; 5: pe45.
98. Duman CH, Schlesinger L, Terwilliger R, Russell DS, Newton SS, Duman RS. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise.Behav Brain Res 2009; 198: 366-71.
99. Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: aroad to remission? Science 2012; 338: 72-5.
100. Conboy L, Varea E, Castro JE, et al. Macrophage migration inhibitoryfactor is critically involved in basal and fluoxetine-stimulatedadult hippocampal cell proliferation and in anxiety, depression, andmemory-related behaviors. Mol Psychiatry 2010; 16: 533-47.
101. Gomez-Pinilla F, Dao L, So V. Physical exercise induces FGF-2and its mRNA in the hippocampus. Brain Res 1997; 764: 1-8.
102. Ding Q, Ying Z, Gomez-Pinilla F. Exercise influences hippocampalplasticity by modulating brain-derived neurotrophic factorprocessing. Neuroscience 2011; 192: 773-80.
103. Pareja-Galeano H, Brioche T, Sanchis-Gomar F, et al. Impact ofexercise training on neuroplasticity-related growth factors in adolescents.J Musculoskelet Neuronal Interact 2013; 13: 330-3.
104. Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity- exercise-induced response of peripheral brain-derived neurotrophicfactor: a systematic review of experimental studies in humansubjects. Sports Med 2010; 40: 765-801.
105. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effectsof brain-derived neurotrophic factor in rodent and primatemodels of Alzheimer's disease. Nat Med 2009; 15: 331-7.
106. Fabel K, Fabel K, Tam B, et al. VEGF is necessary for exerciseinducedadult hippocampal neurogenesis. Eur J Neurosci 2003; 18:2803-12.
107. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activityincreases mRNA for brain-derived neurotrophic factor andnerve growth factor in rat brain. Brain Res 1996; 726: 49-56.
108. Revilla S, Sunol C, Garcia-Mesa Y, Gimenez-Llort L, Sanfeliu C,Cristofol R. Physical exercise improves synaptic dysfunction andrecovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology 2014; 81: 55-63.
109. Koo HM, Lee SM, Kim MH. Spontaneous wheel running exerciseinduces brain recovery via neurotrophin-3 expression followingexperimental traumatic brain injury in rats. J Phys Ther Sci 2013;25: 1103-7.
110. Chung JY, Kim MW, Bang MS, Kim M. Increased expression ofneurotrophin 4 following focal cerebral ischemia in adult rat brainwith treadmill exercise. PLoS One 2013; 8: e52461.
111. Chao MV. Neurotrophins and their receptors: a convergence pointfor many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309.
112. Chang L, Karin M. Mammalian MAP kinase signalling cascades.Nature 2001; 410: 37-40.
113. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signalintegration system subserving synaptic plasticity and memory. JNeurochem 2001; 76: 1-10.
114. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. Reduced activation and expression of ERK1/2 MAPkinase in the post-mortem brain of depressed suicide subjects. JNeurochem 2001; 77: 916-28.
115. Dwivedi Y. Brain-derived neurotrophic factor: role in depressionand suicide. Neuropsychiatr Dis Treat 2009; 5: 433-49.
116. Nakata H, Nakamura S. Brain-derived neurotrophic factor regulatesAMPA receptor trafficking to post-synaptic densities via IP3R andTRPC calcium signaling. FEBS Lett 2007; 581: 2047-54.
117. Binder DK, Scharfman HE. Brain-derived neurotrophic factor.Growth Factors 2004; 22: 123-31.
118. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoidsaffect the expression of brain-derived neurotrophic factorand neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15: 1768-77.
119. Nibuya M, Takahashi M, Russell DS, Duman RS. Repeated stressincreases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999; 267: 81-4.
120. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression durationbut not age predicts hippocampal volume loss in medicallyhealthy women with recurrent major depression. J Neurosci 1999;19: 5034-43.
121. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc NatlAcad Sci USA 1996; 93: 3908-13.
122. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157: 115-8.
123. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkBmRNA in rat brain by chronic electroconvulsive seizure and antidepressantdrug treatments. J Neurosci 1995; 15: 7539-47.
124. Russo-Neustadt A, Beard RC, Cotman CW. Exercise, antidepressantmedications, and enhanced brain derived neurotrophic factorexpression. Neuropsychopharmacology 1999; 21: 679-82.
125. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS.Brain-derived neurotrophic factor produces antidepressant effectsin behavioral models of depression. J Neurosci 2002; 22: 3251-61.
126. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C. Exercise and brainneurotrophins. Nature 1995; 373: 109.
127. Ferris LT, Williams JS, Shen CL. The effect of acute exercise onserum brain-derived neurotrophic factor levels and cognitive function.Med Sci Sports Exerc 2007; 39: 728-34.
128. Schmidt-Kassow M, Schadle S, Otterbein S, et al. Kinetics of serumbrain-derived neurotrophic factor following low-intensity versushigh-intensity exercise in men and women. Neuroreport 2012;23: 889-93.
129. Winter B, Breitenstein C, Mooren FC, et al. High impact runningimproves learning. Neurobiol Learn Mem 2007; 87: 597-609.
130. Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediatesthe efficacy of exercise on synaptic plasticity and cognition.Eur J Neurosci 2004; 20: 2580-90.
131. Murphy DD, Segal M. Morphological plasticity of dendritic spinesin central neurons is mediated by activation of cAMP responseelement binding protein. Proc Natl Acad Sci USA 1997; 94: 1482-7.
132. Miyamoto E. Molecular mechanism of neuronal plasticity: inductionand maintenance of long-term potentiation in the hippocampus.J Pharmacol Sci 2006; 100: 433-42.
133. Cheng A, Wan R, Yang JL, et al. Involvement of PGC-1alpha inthe formation and maintenance of neuronal dendritic spines. NatCommun 2012; 3: 1250.
134. Carlezon WA, Jr., Duman RS, Nestler EJ. The many faces ofCREB. Trends Neurosci 2005; 28: 436-45.
135. Vaynman S, Ying Z, Gomez-Pinilla F. Interplay between brainderivedneurotrophic factor and signal transduction modulators inthe regulation of the effects of exercise on synaptic-plasticity. Neuroscience 2003; 122: 647-57.
136. Garatachea N, Pareja-Galeano H, Sanchis-Gomar F, et al. Exerciseattenuates the major hallmarks of aging. Rejuvenation Res 2015;18: 57-89.
137. Russo-Neustadt AA, Chen MJ. Brain-derived neurotrophic factorand antidepressant activity. Curr Pharm Des 2005; 11: 1495-510.
138. Ding Q, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F. Insulin-like growth factor I interfaces with brain-derived neurotrophicfactor-mediated synaptic plasticity to modulate aspects of exerciseinducedcognitive function. Neuroscience 2006; 140: 823-33.
139. Llorens-Martin M, Torres-Aleman I, Trejo JL. Growth factors asmediators of exercise actions on the brain. Neuromol Med 2008;10: 99-107.
140. Gomez-Pinilla F, Ying Z, Roy RR, Molteni R, Edgerton VR. Voluntaryexercise induces a BDNF-mediated mechanism that promotesneuroplasticity. J Neurophysiol 2002; 88: 2187-95.
141. Eliakim A, Moromisato M, Moromisato D, Brasel JA, Roberts C, Jr., Cooper DM. Increase in muscle IGF-I protein but not IGF-ImRNA after 5 days of endurance training in young rats. Am JPhysiol 1997; 273: R1557-61.
142. Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulatinginsulin-like growth factor I mediates effects of exercise on thebrain. J Neurosci 2000; 20: 2926-33.
143. Dunger DB, Ong KK, Sandhu MS. Serum insulin-like growthfactor-I levels and potential risk of type 2 diabetes. Horm Res 2003; 60 Suppl 3: 131-5.
144. Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. Role ofinsulin-like growth factor I signaling in neurodegenerative diseases.J Mol Med 2004; 82: 156-62.
145. Torres-Aleman I. Insulin-like growth factors as mediators of functionalplasticity in the adult brain. Horm Metab Res 1999; 31: 114-9.
146. Torres Aleman I. Role of insulin-like growth factors in neuronalplasticity and neuroprotection. Adv Exp Med Biol 2005; 567: 243-58.
147. Torres-Aleman I. Serum growth factors and neuroprotective surveillance:focus on IGF-1. Mol Neurobiol 2000; 21: 153-60.
148. Deijen JB, de Boer H, Blok GJ, van der Veen EA. Cognitive impairmentsand mood disturbances in growth hormone deficientmen. Psychoneuroendocrinology 1996; 21: 313-22.
149. Nunez A, Carro E, Torres-Aleman I. Insulin-like growth factor Imodifies electrophysiological properties of rat brain stem neurons.J Neurophysiol 2003; 89: 3008-17.
150. Aleman A, Torres-Aleman I. Circulating insulin-like growth factorI and cognitive function: neuromodulation throughout the lifespan.Prog Neurobiol 2009; 89: 256-65.
151. Trejo JL, Piriz J, Llorens-Martin MV, et al. Central actions ofliver-derived insulin-like growth factor I underlying its procognitiveeffects. Mol Psychiatry 2007; 12: 1118-28.
152. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growthfactor I mediates exercise-induced increases in the number of newneurons in the adult hippocampus. J Neurosci 2001; 21: 1628-34.
153. Trejo JL, Llorens-Martin MV, Torres-Aleman I. The effects ofexercise on spatial learning and anxiety-like behavior are mediatedby an IGF-I-dependent mechanism related to hippocampal neurogenesis.Mol Cell Neurosci 2008; 37: 402-11.
154. Cotman CW, Berchtold NC, Christie LA. Exercise builds brainhealth: key roles of growth factor cascades and inflammation.Trends Neurosci 2007; 30: 464-72.
155. Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physicalexercise against brain insults of different etiology and anatomy. JNeurosci 2001; 21: 5678-84.
156. Breese CR, Ingram RL, Sonntag WE. Influence of age and longtermdietary restriction on plasma insulin-like growth factor-1(IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. JGerontol 1991; 46: B180-7.
157. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulationof the insulin-like growth factors. Endocr Rev 1994; 15: 80-101.
158. Adamo ML, Ma X, Ackert-Bicknell CL, Donahue LR, Beamer WG, Rosen CJ. Genetic increase in serum insulin-like growth factor-I (IGF-I) in C3H/HeJ compared with C57BL/6J mice is associatedwith increased transcription from the IGF-I exon 2 promoter.Endocrinology 2006; 147: 2944-55.
159. Kappeler L, De Magalhaes Filho C, Dupont J, et al. Brain IGF-1receptors control mammalian growth and lifespan through a neuroendocrinemechanism. PLoS Biol 2008; 6: e254.
160. Trejo JL, Carro E, Nunez A, Torres-Aleman I. Sedentary life impairsself-reparative processes in the brain: the role of serum insulin-like growth factor-I. Rev Neurosci 2002; 13: 365-74.
161. Llorens-Martin M, Torres-Aleman I, Trejo JL. Exercise modulatesinsulin-like growth factor 1-dependent and -independent effects onadult hippocampal neurogenesis and behaviour. Mol Cell Neurosci 2010; 44: 109-17.
162. Frank HJ, Pardridge WM, Morris WL, Rosenfeld RG, Choi TB. Binding and internalization of insulin and insulin-like growth factorsby isolated brain microvessels. Diabetes 1986; 35: 654-61.
163. Reinhardt RR, Bondy CA. Insulin-like growth factors cross theblood-brain barrier. Endocrinology 1994; 135: 1753-61.
164. Burgdorf J, Zhang XL, Colechio EM, et al. Insulin-like growthfactor I produces an antidepressant-like effect and elicits N-methyl-D-aspartate receptor independent long-term potentiation of synaptictransmission in medial prefrontal cortex and hippocampus. Int JNeuropsychopharmacol 2015; 192(2), pii: pyv101.
165. Kopczak A, Stalla GK, Uhr M, et al. IGF-I in major depression andantidepressant treatment response. Eur Neuropsychopharmacol 2015; 25: 864-72.
166. Lopez-Lopez C, LeRoith D, Torres-Aleman I. Insulin-like growthfactor I is required for vessel remodeling in the adult brain. ProcNatl Acad Sci USA 2004; 101: 9833-8.
167. Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alphadependentmyokine that drives brown-fat-like development ofwhite fat and thermogenesis. Nature 2012; 481: 463-8.
168. Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampalBDNF through a PGC-1alpha/FNDC5 pathway. CellMetab 2013; 18: 649-59.
169. Harkin A. Muscling in on depression. N Engl J Med 2014; 371:2333-4.
170. Commoner B, Townsend J, Pake GE. Free radicals in biologicalmaterials. Nature 1954; 174: 689-91.
171. Davies KJ, Quintanilha AT, Brooks GA, Packer L. Free radicalsand tissue damage produced by exercise. Biochem Biophys ResCommun 1982; 107: 1198-205.
172. Bloomer RJ. Effect of exercise on oxidative stress biomarkers. AdvClin Chem 2008; 46: 1-50.
173. Radak Z, Chung HY, Goto S. Systemic adaptation to oxidativechallenge induced by regular exercise. Free Radic Biol Med 2008;44: 153-9.
174. Gomez-Cabrera MC, Domenech E, Vina J. Moderate exercise is anantioxidant: upregulation of antioxidant genes by training. FreeRadic Biol Med 2008; 44: 126-31.
175. Ogonovszky H, Berkes I, Kumagai S, et al. The effects of moderate-,strenuous- and over-training on oxidative stress markers, DNArepair, and memory, in rat brain. Neurochem Int 2005; 46: 635-40.
176. Gimenez-Llort L, Garcia Y, Buccieri K, et al. Gender-SpecificNeuroimmunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice. Int J Alzheimers Dis 2010; 2010: 128354.
177. Radak Z, Kaneko T, Tahara S, et al. Regular exercise improvescognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001; 38: 17-23.
178. Garcia-Mesa Y, Pareja-Galeano H, Bonet-Costa V, et al. Physicalexercise neuroprotects ovariectomized 3xTg-AD mice throughBDNF mechanisms. Psychoneuroendocrinology 2014; 45: 154-66.
179. Pareja-Galeano H, Brioche T, Sanchis-Gomar F, et al. Effects ofphysical exercise on cognitive alterations and oxidative stress in anAPP/PSN1 transgenic model of Alzheimer's disease. Rev Esp GeriatrGerontol 2012; 47: 198-204.
180. Hara M, Iigo M, Ohtani-Kaneko R, et al. Administration of melatoninand related indoles prevents exercise-induced cellular oxidativechanges in rats. Biol Signals 1997; 6: 90-100.
181. Somani SM, Ravi R, Rybak LP. Effect of exercise training onantioxidant system in brain regions of rat. Pharmacol Biochem Behav 1995; 50: 635-9.
182. Howren MB, Lamkin DM, Suls J. Associations of depression withC-reactive protein, IL-1, and IL-6: a meta-analysis. PsychosomMed 2009; 71: 171-86.
183. Pedersen BK, Fischer CP. Physiological roles of muscle-derivedinterleukin-6 in response to exercise. Curr Opin Clin Nutr MetabCare 2007; 10: 265-71.
184. Pedersen M, Bruunsgaard H, Weis N, et al. Circulating levels ofTNF-alpha and IL-6-relation to truncal fat mass and muscle mass inhealthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 2003; 124: 495-502.
185. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- andanti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 (Pt 1): 287-91.
186. Kohut ML, McCann DA, Russell DW, et al. Aerobic exercise, butnot flexibility/resistance exercise, reduces serum IL-18, CRP, andIL-6 independent of beta-blockers, BMI, and psychosocial factorsin older adults. Brain Behav Immun 2006; 20: 201-9.
187. Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise trainingon chronic inflammation. Clin Chim Acta 2010; 411: 785-93.
188. Mathur N, Pedersen BK. Exercise as a mean to control low-gradesystemic inflammation. Mediat Inflamm 2008; 2008: 109502.
189. Plaisance EP, Grandjean PW. Physical activity and high-sensitivityC-reactive protein. Sports Med 2006; 36: 443-58.
190. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Crosssectionaland prospective relationships of interleukin-6 and Creactiveprotein with physical performance in elderly persons:MacArthur studies of successful aging. J Gerontol A Biol Sci MedSci 2000; 55: M709-15.
191. Puterman E, Epel ES, Lin J, et al. Multisystem resiliency moderatesthe major depression-telomere length association: findingsfrom the Heart and Soul Study. Brain Behav Immun 2013; 33: 65-73.
192. Verhoeven JE, Revesz D, Epel ES, Lin J, Wolkowitz OM, Penninx BW. Major depressive disorder and accelerated cellular aging: resultsfrom a large psychiatric cohort study. Mol Psychiatry 2014;19(8): 895-901.
193. Cherkas LF, Hunkin JL, Kato BS, et al. The association betweenphysical activity in leisure time and leukocyte telomere length.Arch Intern Med 2008; 168: 154-8.
194. Wolf SA, Melnik A, Kempermann G. Physical exercise increasesadult neurogenesis and telomerase activity, and improves behavioraldeficits in a mouse model of schizophrenia. Brain Behav Immun 2011; 25: 971-80.
195. Botha M, Grace L, Bugarith K, et al. The impact of voluntary exerciseon relative telomere length in a rat model of developmentalstress. BMC Res Notes 2012; 5: 697.
196. Mitchell C, Hobcraft J, McLanahan SS, et al. Social disadvantage,genetic sensitivity, and children's telomere length. Proc Natl AcadSci USA 2014; 111(6): 5944-9.
197. Du M, Prescott J, Kraft P, et al. Physical activity, sedentary behavior,and leukocyte telomere length in women. Am J Epidemiol 2012; 175: 414-22.
198. Savela S, Saijonmaa O, Strandberg TE, et al. Physical activity inmidlife and telomere length measured in old age. Exp Gerontol 2013; 48: 81-4.
199. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampalvolume in patients suffering from depression: a metaanalysis.Am J Psychiatry 2004; 161: 598-607.
200. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidencefor the neurotrophic effects of mood stabilizers: implications forthe pathophysiology and treatment of manic-depressive illness.Biol Psychiatry 2000; 48: 740-54.
201. Bjornebekk A, Mathe AA, Brene S. The antidepressant effect ofrunning is associated with increased hippocampal cell proliferation.Int J Neuropsychopharmacol 2005; 8: 357-68.
202. Pajonk FG, Wobrock T, Gruber O, et al. Hippocampal plasticity inresponse to exercise in schizophrenia. Arch Gen Psychiatry 2010;67: 133-43.
203. Colcombe SJ, Erickson KI, Raz N, et al. Aerobic fitness reducesbrain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003; 58: 176-80.
204. O'Sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS. Evidence for cortical "disconnection" as a mechanismof age-related cognitive decline. Neurology 2001; 57: 632-8.
205. Colcombe SJ, Kramer AF, Erickson KI, Scalf P. The implicationsof cortical recruitment and brain morphology for individual differencesin inhibitory function in aging humans. Psychol Aging 2005;20: 363-75.
206. Vogiatzis I, Louvaris Z, Habazettl H, et al. Frontal cerebral cortexblood flow, oxygen delivery and oxygenation during normoxic andhypoxic exercise in athletes. J Physiol 2011; 589: 4027-39.
207. Berggren KL, Kay JJ, Swain RA. Examining cerebral angiogenesisin response to physical exercise. Methods Mol Biol 2014; 1135:139-54.
208. Van der Borght K, Kobor-Nyakas DE, Klauke K, et al. Physicalexercise leads to rapid adaptations in hippocampal vasculature:temporal dynamics and relationship to cell proliferation and neurogenesis.Hippocampus 2009; 19: 928-36.